Nyt fra tidsskrifterne
Ingen søgeord valgt.
47 emner vises.
BMC Infectious Diseases, 11.09.2024
Tilføjet 11.09.2024
Abstract Background Measles remains a major public health burden worldwide. Parents often hesitate to vaccinate children with chronic diseases. We investigated the association between the percentage of vaccination and chronic diseases and explore hospital infections’ role in the 2017–2019 measles outbreak across northern Vietnam provinces. Methods A total of 2,064 children aged 0–15 years old admitted for measles to the National Children’s Hospital during the outbreak were included in the study. Demographic information, clinical characteristics, vaccination statuses and laboratory examination were extracted from electronic medical records, vaccination records, or interviews with parents when other sources were unavailable. Results The incidence rate that provincial hospitals sent to the National Children’s Hospital was proportional to the population density of their provinces of residence. Early nosocomial transmission of measles was observed before community-acquired cases emerged in many provinces. Among patients aged over 18 months, those with chronic diseases had a proportion of vaccination of 9.4%, lower than patients without chronic diseases at 32.4%. Unvaccinated patients had a higher proportion of hospital-acquired infections with aOR = 2.42 (1.65–3.65), p
Læs mere Tjek på PubMedBMC Infectious Diseases, 11.09.2024
Tilføjet 11.09.2024
Abstract Background Formal assessment of a surveillance system’s features and its ability to achieve objectives is crucial for disease control and prevention. Since the implementation of the mpox surveillance system in Cameroon, no evaluation has been conducted. Methods In a cross-sectional study, we assessed the performance of the mpox surveillance system in accordance with the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) guidelines. We collected mpox surveillance data from 2018 to 2022 and conducted a survey with key stakeholders of the surveillance program. The survey results were summarized. The rates of complete reporting and mpox detection, as well as the time lag between the different stages of surveillance were analyzed using R version 4.1. Results The mpox detection rate was 21.6% (29/134) over the five years under review. Surveillance indicators revealed that a combination of sample types, including vesicles, crust, and blood, was associated with higher case confirmation. Overall, the mpox surveillance system was effective. Weaknesses in terms of simplicity were identified. Most components of the assessed system failed to meet the timeliness and data quality goals, except for the laboratory component, which was commendable. The lack of a computerized shared database and the system’s non-sustainability were a course of concern. Conclusions Despite all identified bottlenecks in the mpox surveillance system in Cameroon, it was found to meet it stipulated goals. Recommendations are made for training on surveillance system features, particularly at the facility/field level. Therefore, there is a crucial need to globally improve the mpox surveillance system in Cameroon for better disease control.
Læs mere Tjek på PubMedBMC Infectious Diseases, 11.09.2024
Tilføjet 11.09.2024
Abstract Purpose To evaluate the diagnosis and management of bacterial meningitis in adult Sudanese patients in accordance with the Infectious Diseases Society of America (IDSA) guidelines for bacterial meningitis management. Patients and methods A cross-sectional, retrospective study design was used to recruit all patients aged > 18 years who were diagnosed with or suspected of having bacterial meningitis and admitted to Wad Medani Teaching Hospital, Gezira State, Sudan, between January 2017 and October 2022. Results In total, 201 patients were included in the analysis. The mean age of the participants was 44.1 ± 21.4 years, and 107 (53.2%) were male. Community-acquired bacterial meningitis accounted for 193 (96%) of the studied patients, and only 8 (4%) of the patients had healthcare-associated meningitis. Neuroimaging was utilized appropriately in 148 (73.6%) patients, blood cultures were not performed entirely, and lumbar puncture was seldom performed in 1 (0.5%) patient. Corticosteroids were appropriately administered to 65 (32.3%) patients, and antibiotics were administered appropriately to only 5 (2.5%) patients. Ceftriaxone 185 (76.1%) was the most frequently utilized antibiotic, followed by vancomycin 23 (9.5%). In terms of overall adherence, this study demonstrated that the IDSA guidelines were not followed at all in the treatment of patients with suspected bacterial meningitis. Conclusion The results of this study contradict the IDSA guidelines for the standard of care for bacterial meningitis. Antibiotic regimens are often incorrect, corticosteroids are administered appropriately in approximately one-third of patients, and neuroimaging is reasonably utilized. This study raises attention to several important issues regarding the diagnosis of bacterial meningitis, including the lack of confirming microbiological tests and the reliance of the diagnosis primarily on CT and clinical examination.
Læs mere Tjek på PubMedBMC Infectious Diseases, 11.09.2024
Tilføjet 11.09.2024
Abstract Background Even though tuberculosis is a common disease among children in developing countries, tuberculous dactylitis is an uncommon form of Skeletal tuberculosis specially with involvement of both the hands and feet. Case Presentation A one-and-a-half-year-old previously healthy female Ethiopian toddler presented to our pediatric outpatient clinic with a history of two-month duration of painful multiple swellings over both her hands and feet. The swelling involved the proximal phalanx of the left index finger, dorsum of the right hand, and dorsum of both feet over the first metatarsal bone. Physical examination, radiologic findings, and histopathology suggested tuberculous dactylitis. The patient was treated with anti-tuberculosis drugs for one year and she showed clinical and radiologic improvement and recovery. Conclusion Tubercular dactylitis should be considered in the differential diagnosis of children from endemic areas presenting with bone and joint pain or swelling. Our experience of a twelve-month course of antitubercular treatment, which is in line with WHO recommendations, for skeletal tuberculosis, showed excellent outcomes.
Læs mere Tjek på PubMedBMC Infectious Diseases, 11.09.2024
Tilføjet 11.09.2024
Abstract Background Premature infants have less physiologic reserve and often delayed vaccination compared to full-term infants. The birth dose of hepatitis B vaccine (HepB-BD) is an essential measure to achieve the goal of "zero infections" of hepatitis B virus in all newborns. However, there are few investigations of hepatitis B vaccination of preterm infants, leading to uncertainty of coverage and insufficient knowledge of factors influencing timely vaccination of this important population. Methods We obtained hepatitis B vaccine (HepB) vaccination histories of premature infants born during 2019–2021 in three provinces from the respective provincial immunization information systems. Extracted data included date of birth, sex, region, and dates of HepB administration. We conducted descriptive analyses that included basic characteristics of the study subjects, HepB-BD administration, and full-series HepB vaccination. Factors potentially influencing HepB-BD and full series vaccination were analyzed by logistic regression. Results There were 1623 premature infants included in the analytic data set. Overall HepB-BD coverage was 71.41%; coverage among premature infants born to mothers with unknown hepatitis B surface antigen (HBsAg) status was 69.57%; coverage was higher at county-level-and-above hospitals (72.02%) than hospitals below county level (61.11%). Full-series HepB coverage was 94.15%; full-series coverage among preterm infants weighing less than 2000 g at birth was 76.92%. Logistic regression showed that the HepB-BD vaccination rate was positively associated with being born to an HBsAg-positive mother and being preterm with high birth weight. Regression analysis for factors influencing full-series HepB coverage showed that being born prematurely was positively associated with full-series coverage and being premature with a very low birth weight was negatively associated with full-series coverage. Conclusions HepB-BD coverage levels in three provinces of China were less than the target of 90%, especially among premature infants born to mothers with unknown HBsAg status and at hospitals below the county level. Screening of pregnant women should be a universal normal standard. Hepatitis B vaccination training should be strengthened in hospitals to improve the HepB-BD vaccination rate of premature infants and to effectively prevent mother-to-child transmission of hepatitis B virus.
Læs mere Tjek på PubMedAubrey K. G. McReynolds Emma A. Pagella Miranda J. Ridder Olivia Rippee Zachary Clark Michaella J. Rekowski Michele T. Pritchard Jeffrey L. Bose a Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, KS, USAb The Mass Spectrometry and Proteomics Core, University of Kansas Medical Center, Kansas City, KS, USAc Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USAd Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA
Virulence, 11.09.2024
Tilføjet 11.09.2024
Nan ZhangRui ZhangLei JiangZhaoyu GaoWenzhen XiaXiaoying MaYushi QinDi ZhangJiazheng LiPei TianQi ZhangWanchang WangKaixia ZhangShan XuNa ZhaoShunjiang XuaCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People’s Republic of ChinabHebei International Joint Research Center for Brain Science, Shijiazhuang 050031, People’s Republic of ChinacHebei Key Laboratory of Brain Science and Psychiatric-Psychologic Disease, Shijiazhuang 050031, People’s Republic of ChinadResearch Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, Chinese Academy of Medical Sciences, Beijing 100730, People’s Republic of China
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedYinan WangShan GaoFangyu WuYicheng GongNengjiang MuChuancun WeiChengyao WuJun WangNing YanHuifang YangYifan ZhangJiayi LiuZeyu WangXiuna YangSin Man LamGuanghou ShuiSiyuan LiLintai DaLuke W. GuddatZihe RaoLu ZhangaState Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300353, ChinabShanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, ChinacShanghai Clinical Research and Trial Center, Shanghai 201210, ChinadSchool of Life Sciences, Tianjin University, Tianjin 300072, ChinaeState Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, ChinafKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, ChinagSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, AustraliahLaboratory of Structural Biology, Tsinghua University, Beijing 10084, China
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedBaolian HuangTe YinShuilian FuLina LiuChen YangLulu ZhouXing LiuHongqin ZhuangZhiting CaoZichun HuaaSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of ChinabThe State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing, People’s Republic of ChinacChangzhou High-Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories Inc., Changzhou 213164, People’s Republic of China
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedXi-Le HuHui-Qi GanWen-Zhen GuiKai-Cheng YanJonathan L. SesslerDong YiHe TianXiao-Peng HeaKey Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Prize Scientist Joint Research Center, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, ChinabNational Center for Liver Cancer, The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, ChinacDepartment of Chemistry, University of Bath, Bath BA2 7AY, United KingdomdDepartment of Chemistry, The University of Texas at Austin, Austin, TX 78712-1224eResearch Center for Systems Biosynthesis, China State Institute of Pharmaceutical Industry, National Key Laboratory of Lead Druggability Research, Shanghai 201203, China
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedScott ChimileskiGary G. BorisyFloyd E. DewhirstJessica L. Mark WelchaJosephine Bay Paul Center for Comparative Molecular Biology and Evolution, Marine Biological Laboratory, Woods Hole, MA 02543bDepartment of Microbiology, American Dental Association Forsyth Institute, Cambridge, MA 02142cDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA 02115
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedTom Le VoyerMajistor Raj Luxman Maglorius RenkilarajKunihiko MoriyaMalena Pérez LorenzoTina NguyenLiwei GaoTamar RubinAxel CederholmMasato OgishiCarlos A. Arango-FrancoVivien BéziatRomain LévyMélanie MigaudFranck RapaportYuval ItanElissa K. DeenickIrene CorteseAndrea LiscoKaan BoztugLaurent AbelStéphanie Boisson-DupuisBertrand BoissonPatrick FroskCindy S. MaNils LandegrenFatih CelmeliJean-Laurent CasanovaStuart G. TangyeAnne PuelaLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Paris 75015, FrancebImagine Institute, Paris Cité University, Paris 75015, FrancecClinical Immunology Department, Assistance Publique Hôpitaux de Paris, Saint-Louis Hospital, Paris 75010, FrancedGarvan Institute of Medical Research, Darlinghurst, NSW 2010, AustraliaeSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales Sydney, Sydney, NSW 2052, AustraliafDivision of Pediatric Clinical Immunology and Allergy, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB R3A 1S1, CanadagScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala SE-751 05, SwedenhSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065iGroup of Inborn Errors of Immunity, Department of Microbiology and Parasitology, School of Medicine, University of Antioquia, Medellín 050010, ColombiajDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029kExperimental Immunotherapeutics Unit, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892lLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892mSt. Anna Children’s Cancer Research Institute, Vienna 1090, AustrianMedical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna 1090, AustriaoCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, AustriapDepartment of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, CanadaqDepartment of Allergy and Immunology, University of Medical Science, Antalya Education and Research Hospital, Antalya 07100, TürkiyerPediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, Paris 75015, FrancesHHMI, New York, NY 10065
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedMadeline R. SponholtzPatrick O. ByrneAlison G. LeeAjit R. RamamohanJory A. GoldsmithRyan S. McCoolLing ZhouNicole V. JohnsonChing-Lin HsiehMegan ConnorsKrithika P. KarthigeyanChelsea M. CrooksAdelaide S. FullerJohn D. CampbellSallie R. PermarJennifer A. MaynardDong YuMatthew J. BottomleyJason S. McLellanaDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712bDivision of Infectious Diseases, Department of Pediatrics, Weill Cornell Medicine, New York, NY 10065cDynavax Technologies Corporation, Emeryville, CA 94608dDepartment of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedShin-ichiro HattoriHaydar BulutHironori HayashiNaoki KishimotoNobutoki TakamuneKazuya HasegawaYuri FurusawaSeiya YamayoshiKazutaka MurayamaHirokazu TamamuraMi LiAlexander WlodawerYoshihiro KawaokaShogo MisumiHiroaki MitsuyaaDepartment of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, JapanbExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, MD 20892cDivision of Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, Miyagi 980-8575, JapandDepartment of Environmental and Molecular Health Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, JapaneStructural Biology Division, Japan Synchrotron Radiation Research Institute, Hyogo 679-5198, JapanfDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, JapangThe Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, JapanhInternational Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, JapaniDivision of Biomedical Measurements and Diagnostics, Graduate School of Biomedical Engineering, Tohoku University, Miyagi 980-8575, JapanjDepartment of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo 101-0062, JapankCenter for Structural Biology, National Cancer Institute, Frederick, MD 21702lBasic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702mDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin–Madison, Madison, WI 53711nDepartment of Clinical Sciences, Kumamoto University Hospital, Kumamoto 860-8556, Japan
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedConor J. LoyVenice ServellitaAlicia Sotomayor-GonzalezAndrew BlissJoan S. LenzEmma BelcherWill SuslovicJenny NguyenMeagan E. WilliamsMiriam OsegueraMichael A. GardinerJong-Ha ChoiHui-Mien HsiaoHao WangJihoon KimChisato ShimizuAdriana H. TremouletMeghan DelaneyRoberta L. DeBiasiChristina A. RostadJane C. BurnsCharles Y. ChiuIwijn De VlaminckaMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14850bDepartment of Laboratory Medicine, University of California, San Francisco, CA 94143cDivision of Pediatric Infectious Disease, Children’s National Hospital, Washington, DC 20010dDepartment of Pediatrics, Rady Children’s Hospital-San Diego, San Diego, CA 92123eDepartment of Pediatrics, Kawasaki Disease Research Center, University of California San Diego, La Jolla, CA 92093fDivision of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30307gCenter for Childhood Infections and Vaccines, Children’s Healthcare of Atlanta, Atlanta, GA 30322hDepartment of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT 06510iDepartment of Pediatrics, George Washington University, School of Medicine & Health Sciences, Washington, DC 20052jDepartment of Medicine, Division of Infectious Diseases, University of California, San Francisco, CA 94158kChan-Zuckerberg Biohub, San Francisco, CA 94158Lukas Austin-PageAmy BrylJoelle Donofrio-ÖdmannAtim EkpenyongDavid GutglassScott HerskovitzPaul IshimineJohn KanegayeMargaret NguyenMylinh NguyenKristy SchwartzStacey UlrichTatyana VayngortinElise ZimmermanJocelyn AngMargalit RosenkranzJoseph BochiniMichelle SykesLerraughn MorganLaura D’AddeseMaria Pilar Gutierrez
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedMiriam H. RichardsaDepartment of Biological Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada
Proceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedProceedings of the National Academy of Sciences, 11.09.2024
Tilføjet 11.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 37, September 2024.
Læs mere Tjek på PubMedAndrea Du Toit
Nat Rev Microbiol, 11.09.2024
Tilføjet 11.09.2024
FEMS Microbiology Reviews, 11.09.2024
Tilføjet 11.09.2024
Abstract Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes widespread changes in epigenetic modifications and chromatin architecture in the host cell. Recent evidence suggests that SARS-CoV-2 non-structural protein 1 (nsp1) plays an important role in driving these changes. Previously thought to be primarily involved in host translation shutoff and cellular mRNA degradation, nsp1 has now been shown to be a truly multifunctional protein that affects host gene expression at multiple levels. The functions of nsp1 are surprisingly diverse and include not only the downregulation of cellular mRNA translation and stability, but also the inhibition of mRNA export from the nucleus, the suppression of host immune signaling, and, most recently, the epigenetic regulation of host gene expression. In this review, we first summarize the current knowledge on SARS-CoV-2-induced changes in epigenetic modifications and chromatin structure. We then focus on the role of nsp1 in epigenetic reprogramming, with a particular emphasis on the silencing of immune-related genes. Finally, we discuss potential molecular mechanisms underlying the epigenetic functions of nsp1 based on evidence from SARS-CoV-2 interactome studies.
Læs mere Tjek på PubMedÉric Bergeron Cheng-Feng Chiang Michael K. Lo Elif Karaaslan Syed Moinuddin Satter Mohammed Ziaur Rahman Mohammad Enayet Hossain Wasik Rahman Aquib Dewan Imtiaz Rahman Subyeta Binte Sarwar Joel M. Montgomery John D. Klena Christina F. Spiropoulou a Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USAb Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, USAc icddr,b, Dhaka, Bangladesh
Emerg Microbes Infect, 10.09.2024
Tilføjet 10.09.2024
Yue Yao Tailong Lei Junbo Gao Qingye Xu Lei Xu Buhui Zhao Shangshang Qin Yunsong Yu Xiaoting Hua a Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of Chinab Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, People’s Republic of Chinac Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of Chinad Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, People’s Republic of Chinae Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, People’s Republic of Chinaf School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, People’s Republic of Chinag Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou, People’s Republic of China
Emerg Microbes Infect, 10.09.2024
Tilføjet 10.09.2024
Jinyan Shen Hong Zhang Xiaohong Sun Yaping Zhang Mengjing Wang Mengdi Guan Lili Liu Wenxi Li Hongke Xu Yujiao Xie Anran Ren Fengyang Cao Wenqiang Liu Guohua Deng Jing Guo Xuyong Li a College of Agriculture and Biology, Liaocheng University, Liaocheng, People’s Republic of Chinab Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, State Key Laboratory for Animal Disease Control and Prevention, Harbin, People’s Republic of China
Emerg Microbes Infect, 10.09.2024
Tilføjet 10.09.2024
Wei-Li Hsu, Chung-Lun Chen, Shi-Wei Huang, Chia-Chen Wu, I-Hsuan Chen, Muthukumar Nadar, Yin-Peng Su, Ching-Hsiu Tsai
PLoS One Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
by Wei-Li Hsu, Chung-Lun Chen, Shi-Wei Huang, Chia-Chen Wu, I-Hsuan Chen, Muthukumar Nadar, Yin-Peng Su, Ching-Hsiu Tsai
Læs mere Tjek på PubMedAbdualrahman Saeed Alshehry
PLoS One Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
by Abdualrahman Saeed Alshehry This study assessed the resilience of nurses in Saudi Arabia during the corona virus 2019 (COVID-19) pandemic and examined its influence on their quality of life (QOL). A sample of 356 nurses was surveyed in this quantitative, cross-sectional study using the Resilience Scale for Nurses and the World Health Organization Quality of Life (WHOQOL-BREF) from October 2020 to March 2021. The nurses reported the highest resilience score on “situational pattern”, while the lowest score was on “relational pattern.” The nurses had good perceptions on their overall QOL and health and rated their “social relationship” as having the highest quality, while their “environmental” domain as having the least quality. Gender, marital status, provision of direct nursing care to COVID-19 patients, “philosophical pattern”, “situational pattern” and “dispositional pattern” had multivariate impacts on the QOL dimensions. The study concluded that being resilient can positively impact the nurses’ QOL during stressful situations, such as the COVID-19 pandemic.
Læs mere Tjek på PubMedJulia Smith, Muhammad Haaris Tiwana, Alice Murage, Hasina Samji, Rosemary Morgan, Jorge Andres Delgado-Ron
PLoS One Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
by Julia Smith, Muhammad Haaris Tiwana, Alice Murage, Hasina Samji, Rosemary Morgan, Jorge Andres Delgado-Ron While there is growing literature on experiences of healthcare workers and those providing unpaid care during COVID-19, little research considers the relationships between paid and unpaid care burdens and contributions. We administered a moral distress survey to healthcare workers in Canada, in 2022, collecting data on both paid and unpaid care. There were no significant differences in the proportion of participants providing unpaid care by gender, with both genders equally affected by certain responsibilities such as reduced contact with family/loved ones. However, men were significantly more distressed about specific unpaid care responsibilities. Unpaid care was not significantly associated with differences in intention to leave work. At work, women were significantly more concerned about patients unable to see family, while men were distressed by others mistreating COVID patients. This study enhances understanding of paid and unpaid care relationships, particularly during crises, and proposes an innovative method for assessing unpaid care burdens.
Læs mere Tjek på PubMedSonoko Matsumoto, Takashi Shimizu, Akihiko Uda, Kenta Watanabe, Masahisa Watarai
PLoS One Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
by Sonoko Matsumoto, Takashi Shimizu, Akihiko Uda, Kenta Watanabe, Masahisa Watarai Francisella tularensis is a causative agent of the zoonotic disease tularemia, and is highly pathogenic to humans. The pathogenicity of this bacterium is largely attributed to intracellular growth in host cells. Although several bacterial factors important for the intracellular growth have been elucidated, including the type VI secretion system, the host factors involved in the intracellular growth of F. tularensis are largely unknown. To identify the host factors important for F. tularensis infection, 368 compounds were screened for the negative regulation of F. tularensis subsp. novicida (F. novicida) infection. Consequently, 56 inhibitors were isolated that decreased F. novicida infection. Among those inhibitors, we focused on cucurbitacin I, an inhibitor of the JAK2/ STAT3 pathway. Cucurbitacin I and another JAK2/STAT3 inhibitor, Stattic, decreased the intracellular bacterial number of F. novicida. However, these inhibitors failed to affect the cell attachment or the intrasaccular proliferation of F. novicida. In addition, treatment with these inhibitors destabilized actin filaments. These results suggest that the JAK2/STAT3 pathway plays an important role in internalization of F. novicida into host cells through mechanisms involving actin dynamics, such as phagocytosis.
Læs mere Tjek på PubMedSimone Leo, Michael R. Crusoe, Laura Rodríguez-Navas, Raül Sirvent, Alexander Kanitz, Paul De Geest, Rudolf Wittner, Luca Pireddu, Daniel Garijo, José M. Fernández, Iacopo Colonnelli, Matej Gallo, Tazro Ohta, Hirotaka Suetake, Salvador Capella-Gutierrez, Renske de Wit, Bruno P. Kinoshita, Stian Soiland-Reyes
PLoS One Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
by Simone Leo, Michael R. Crusoe, Laura Rodríguez-Navas, Raül Sirvent, Alexander Kanitz, Paul De Geest, Rudolf Wittner, Luca Pireddu, Daniel Garijo, José M. Fernández, Iacopo Colonnelli, Matej Gallo, Tazro Ohta, Hirotaka Suetake, Salvador Capella-Gutierrez, Renske de Wit, Bruno P. Kinoshita, Stian Soiland-Reyes Recording the provenance of scientific computation results is key to the support of traceability, reproducibility and quality assessment of data products. Several data models have been explored to address this need, providing representations of workflow plans and their executions as well as means of packaging the resulting information for archiving and sharing. However, existing approaches tend to lack interoperable adoption across workflow management systems. In this work we present Workflow Run RO-Crate, an extension of RO-Crate (Research Object Crate) and Schema.org to capture the provenance of the execution of computational workflows at different levels of granularity and bundle together all their associated objects (inputs, outputs, code, etc.). The model is supported by a diverse, open community that runs regular meetings, discussing development, maintenance and adoption aspects. Workflow Run RO-Crate is already implemented by several workflow management systems, allowing interoperable comparisons between workflow runs from heterogeneous systems. We describe the model, its alignment to standards such as W3C PROV, and its implementation in six workflow systems. Finally, we illustrate the application of Workflow Run RO-Crate in two use cases of machine learning in the digital image analysis domain.
Læs mere Tjek på PubMedApeksha AnandGunjan GautamGaurava SrivastavaShailendra YadavKarthik RamalingamMohammad Imran SiddiqiNeena Goyal1Division of Biochemistry and Structural Biology, CSIR—Central Drug Research Institute, Lucknow, Uttar Pradesh, India2Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, IndiaJeroen P. J. Saeij
Infection and Immunity, 10.09.2024
Tilføjet 10.09.2024
Rachael D. FitzPatrickJonathan R. NooneRichard A. CartwrightDominique M. GattiTara P. BrosschotJenna M. LaneErik L. JensenIsabella Kroker KimberLisa A. Reynolds1Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, CanadaManuela Raffatellu
Infection and Immunity, 10.09.2024
Tilføjet 10.09.2024
Infection, 10.09.2024
Tilføjet 10.09.2024
Abstract Purpose A host-protein signature score, consisting of serum-concentrations of C-reactive protein, tumour necrosis factor-related apoptosis-inducing ligand, and interferon gamma-induced protein 10, was validated for distinguishing between bacterial and viral infections as an antimicrobial stewardship measure for routine clinical practice among adult patients in a German tertiary hospital. Methods This single-centre, explorative study prospectively assessed the host-protein signature score, comparing it with serum procalcitonin (PCT) in patients with blood stream infections (BSI) and evaluating its efficacy in patients with viral infections against the standard of care (SOC) to assess the need for antibiotics due to suspected bacterial super/coinfection. Manufacturer-specified threshold scores were used to differentiate viral ( 65) infections. Results Ninety-seven patients (BSI [n = 56]; viral infections [n = 41]) were included. The score (cut-off score > 65) tended to detect BSI with higher sensitivity than did PCT (cut-off > 0.5 ng/mL) (87.5% vs. 76.6%). Three patients (5.4%) with BSI had a score 65, indicating bacterial superinfections. Additionally, 11 patients (26.8%) had scores
Læs mere Tjek på PubMedInfection, 10.09.2024
Tilføjet 10.09.2024
Abstract Introduction Despite national guidelines and use of intrapartum antibiotic prophylaxis (IAP), Streptococcus agalactiae (group B streptococci (GBS)) is still a leading cause of morbidity and mortality in newborns in Europe and the United States. The European DEVANI (Design of a Vaccine Against Neonatal Infections) program assessed the neonatal GBS infection burden in Europe, the clinical characteristics of colonized women and microbiological data of GBS strains in colonized women and their infants with early-onset disease (EOD). Methods Overall, 1083 pregnant women with a GBS-positive culture result from eight European countries were included in the study. Clinical obstetrical information was collected by a standardized questionnaire. GBS strains were characterized by serological and molecular methods. Results Among GBS carriers included in this study after testing positive for GBS by vaginal or recto-vaginal sampling, 13.4% had at least one additional obstetrical risk factor for EOD. The five most common capsular types (i.e., Ia, Ib, II, III and V) comprised ~ 93% of GBS carried. Of the colonized women, 77.8% received any IAP, and in 49.5% the IAP was considered appropriate. In our cohort, nine neonates presented with GBS early-onset disease (EOD) with significant regional heterogeneity. Conclusions Screening methods and IAP rates need to be harmonized across Europe in order to reduce the rates of EOD. The epidemiological data from eight different European countries provides important information for the development of a successful GBS vaccine.
Læs mere Tjek på PubMedLucile PlumetDenis CostechareyreJean-Philippe LavigneKarima KissaVirginie Molle1VBIC, INSERM U1047, University of Montpellier, Montpellier, France2Greenphage, Cap Alpha, Clapiers, France3VBIC, INSERM U1047, University of Montpellier, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Nîmes, FranceBenjamin P. Howden
Antimicrobial Agents And Chemotherapy, 10.09.2024
Tilføjet 10.09.2024
Sayantika Dey, Monalisa Mohanty, Prabhudutta Mamidi, Suprava Naik, Kavita Gupta, Bhagirathi Dwibedi, Sujata Devi, Ashoka Mahapatra, Rashmi Ranjan Das, Bijayini Behera, Sanjeev Kumar Bhoi, Baijayantimala Mishra
Journal of Medical Virology, 10.09.2024
Tilføjet 10.09.2024
Marianna Karachaliou, Otavio Ranzani, Ana Espinosa, Susana Iraola‐Guzmán, Gemma Castaño‐Vinyals, Marta Vidal, Alfons Jiménez, Marc Bañuls, Eva Alonso Nogués, Ruth Aguilar, Judith Garcia‐Aymerich, Rafael de Cid, Carlota Dobaño, Gemma Moncunill, Manolis Kogevinas
Journal of Medical Virology, 10.09.2024
Tilføjet 10.09.2024
Laetitia Gay, Valérie Desquiret‐Dumas, Nicolas Nagot, Clara Rapenne, Philippe Van de Perre, Pascal Reynier, Jean‐Pierre Molès
Journal of Medical Virology, 10.09.2024
Tilføjet 10.09.2024
Clinical & Experimental Immunology, 10.09.2024
Tilføjet 10.09.2024
Abstract Amlexanox (ALX) is a small molecule drug for the treatment of inflammatory, autoimmune, metabolic and tumor diseases. At present, there are no studies on whether ALX has a therapeutic effect on inflammatory bowel disease (IBD). In this study, we used a mouse model of dextran sulfate sodium (DSS)-induced colitis to investigate the effect of ALX targeted inhibition of TBK1 on colitis. We found that the severity of colitis in mice was correlated with TBK1 expression. Notably, although ALX inhibited the activation of the TBK1-NF-κB/TBK1-IRF3 pro-inflammatory signaling pathway, it exacerbated colitis and reduced survival in mice. The results of drug safety experiments ruled out a relationship between this exacerbating effect and drug toxicity. In addition, ELISA results showed that ALX promoted the secretion of IL-1β and IFN-α, and inhibited the production of cytokines IL-6, TNF-α, IL-10, TGF-β and secretory IgA. Flow cytometry results further showed that ALX promoted T cell proliferation, activation and differentiation, and thus played a pro-inflammatory role; Also, ALX inhibited the generation of dendritic cells and the polarization of macrophages to M1 type, thus exerting anti-inflammatory effect. These data suggest that the regulation of ALX on the function of different immune cells is different, so the effect on the inflammatory response is bidirectional. In conclusion, our study demonstrates that simply inhibiting TBK1 in all immune cells is not effective for the treatment of colitis. Further investigation the anti-inflammatory mechanism of ALX on dendritic cells and macrophages may provide a new strategy for the treatment of IBD.
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background While COVID-19 has been controlled and deaths have decreased, the long-term consequences of COVID-19 remain a challenge we face today. This study was conducted to determine the relationship between the apoptosis of lymphocyte cells with DNA damage and oxidative stress and the therapeutic and clinical outcomes of elderly patients with COVID-19. Methods This study was conducted from April 2020 to May 2021 (the period of severe attacks of the epidemic peak of COVID-19) and September 2022 (the post-COVID-19 period). The study groups included elderly patients with COVID-19 hospitalized in the ICU and normal wards of the hospital as well as elderly patients with influenza. A polymerase chain reaction was used to check the validity of the studied diseases. The Annexin V/Propidium Iodide method was used to evaluate the level of apoptosis. Genotoxic effects and DNA damage were assessed by the comet assay method. Total antioxidant status (TAS), total oxidant status (TOS), and myeloperoxidase activity (MPO) were measured by photometric methods. Results The highest level of apoptosis in peripheral blood lymphocytes and the highest level of DNA damage were observed at both times in the intubated-ICU and non-intubated-ICU groups. In all groups, there was a significant increase in peripheral blood lymphocyte apoptosis levels and DNA damage levels compared to the healthy control group (p
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Aims This study aims to evaluate the presence of EBV, HCMV, and BKV genomic sequences in the plasma samples (active infection/viremia) of kidney transplant recipients suspected of rejection and to investigate host and risk factors related to the activation of these viruses in these patients. Methods In this cross-sectional single-center study, plasma samples were collected from 98 suspected kidney transplant rejection patients at Labafinejad Hospital, Tehran, Iran, between December 2022 and June 2023. Quantitative real-time PCR assays for HCMV, EBV, and BK were performed using GeneProof Real-time PCR kits. ROC curve analysis was used to determine the viral load cutoff point for each virus. Findings HCMV active viremia was detected in 18 (18.36%) recipients, EBV active viremia in 7 (7.14%), and BKV active viremia in 5 (5.10%). ROC results indicated viral load cutoff points of 778, 661, and 457 points for HCMV, EBV, and BKV, respectively. The duration of time after transplantation significantly differed between active viremia and no viremia groups (120.5 vs. 46 months, P = 0.014). In the BKV active viremia group, the increase in creatinine compared to baseline creatinine was significantly higher than in the no viremia group (2.7 vs. 0.8, P = 0.017). The odds ratio of HCMV active viremia in patients taking tacrolimus was 2.84 times higher, and the odds of HCMV active viremia in patients taking antithymocyte globulin was 3.01 times higher than in patients not taking these drugs. Conclusion Rapid and timely diagnosis of viral active infections in kidney transplant patients is crucial for effective disease management and implementation of appropriate treatment strategies. Identifying potential risk factors, including host and treatment-related factors that influence transplantation, can facilitate the development of suitable preventive strategies.
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background The use of antiretrovirals has increased the survival of People Living with HIV/AIDS (PLWHA), resulting in an aging population and a rise in the incidence of sarcopenia. The lack of uniformity among the prevalences found in studies may be associated with the use of different diagnostic criteria, highlighting the need for local studies to determine the prevalence of sarcopenia. Methods Cross-sectional study to estimate the prevalence and associated factors of sarcopenia using the revised criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2). This study included PLWHA of both sexes, aged 40 years or older, who were treated at the infectious disease outpatient clinic of a tertiary hospital from 2019 to 2021. Muscle mass was quantified through electrical bioimpedance, using resistance and reactance to calculate appendicular lean mass (ALM) in kg/m². Muscle strength, measured in kg, was assessed using a manual dynamometer, and muscle function was evaluated using the gait speed test (m/s). Numerical variables were analyzed using measures of central tendency and dispersion. The chi-square test was used to assess associations in categorical variables. Odds ratios (OR) and 95% Confidence Intervals (CI) were calculated to evaluate the strength of associations. Results Among the 218 PLWHA, the prevalence of sarcopenia was 8.7% (95% CI: 5.6 to 13.3). The mean age of the study population was 51.8 ± 8.3 years; 53.7% were male, 72.9% were brown/Black, 97.7% reported not using illicit drugs, and 24.8% were classified as obese. Multivariate analysis showed that the time since HIV diagnosis (P = 0.022) and the use of illicit drugs were associated with the diagnosis of sarcopenia. Conclusion The prevalence of sarcopenia using the EWGSOP2 criteria was low. People with a longer duration of HIV infection and those using illicit drugs were more likely to develop sarcopenia.
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background Coinfection with two phylogenetically distinct Human Immunodeficiency Virus-1 (HIV-1) variants might provide an opportunity for rapid viral expansion and the emergence of fit variants that drive disease progression. However, autologous neutralising immune responses are known to drive Envelope (Env) diversity which can either enhance replicative capacity, have no effect, or reduce viral fitness. This study investigated whether in vivo outgrowth of coinfecting variants was linked to pseudovirus and infectious molecular clones’ infectivity to determine whether diversification resulted in more fit virus with the potential to increase disease progression. Results For most participants, emergent recombinants displaced the co-transmitted variants and comprised the major population at 52 weeks postinfection with significantly higher entry efficiency than other co-circulating viruses. Our findings suggest that recombination within gp41 might have enhanced Env fusogenicity which contributed to the increase in pseudovirus entry efficiency. Finally, there was a significant correlation between pseudovirus entry efficiency and CD4 + T cell count, suggesting that the enhanced replicative capacity of recombinant variants could result in more virulent viruses. Conclusion Coinfection provides variants with the opportunity to undergo rapid recombination that results in more infectious virus. This highlights the importance of monitoring the replicative fitness of emergent viruses.
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background Bacillus anthracis is a highly pathogenic bacterium that can cause lethal infection in animals and humans, making it a significant concern as a pathogen and biological agent. Consequently, accurate diagnosis of B. anthracis is critically important for public health. However, the identification of specific marker genes encoded in the B. anthracis chromosome is challenging due to the genetic similarity it shares with B. cereus and B. thuringiensis. Methods The complete genomes of B. anthracis, B. cereus, B. thuringiensis, and B. weihenstephanensis were de novo annotated with Prokka, and these annotations were used by Roary to produce the pan-genome. B. anthracis exclusive genes were identified by Perl script, and their specificity was examined by nucleotide BLAST search. A local BLAST alignment was performed to confirm the presence of the identified genes across various B. anthracis strains. Multiplex polymerase chain reactions (PCR) were established based on the identified genes. Result The distribution of genes among 151 whole-genome sequences exhibited three distinct major patterns, depending on the bacterial species and strains. Further comparative analysis between the three groups uncovered thirty chromosome-encoded genes exclusively present in B. anthracis strains. Of these, twenty were found in known lambda prophage regions, and ten were in previously undefined region of the chromosome. We established three distinct multiplex PCRs for the specific detection of B. anthracis by utilizing three of the identified genes, BA1698, BA5354, and BA5361. Conclusion The study identified thirty chromosome-encoded genes specific to B. anthracis, encompassing previously described genes in known lambda prophage regions and nine newly discovered genes from an undefined gene region to the best of our knowledge. Three multiplex PCR assays offer an accurate and reliable alternative method for detecting B. anthracis. Furthermore, these genetic markers have value in anthrax vaccine development, and understanding the pathogenicity of B. anthracis.
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background HIV-1 has well-established mechanisms to disrupt essential pathways in people with HIV, such as inflammation and metabolism. Moreover, diversity of the amino acid sequences in fundamental HIV-1 proteins including Tat and Vif, have been linked to dysregulating these pathways, and subsequently influencing clinical outcomes in people with HIV. However, the relationship between Tat and Vif amino acid sequence variation and specific immune markers and metabolites of the tryptophan-kynurenine (Trp-Kyn) pathway remains unclear. Therefore, this study aimed to investigate the relationship between Tat/Vif amino acid sequence diversity and Trp-Kyn metabolites (quinolinic acid (QUIN), Trp, kynurenic acid (KA), Kyn and Trp/Kyn ratio), as well as specific immune markers (sCD163, suPAR, IL-6, NGAL and hsCRP) in n = 67 South African cART-naïve people with HIV. Methods Sanger sequencing was used to determine blood-derived Tat/Vif amino acid sequence diversity. To measure Trp-Kyn metabolites, a LC–MS/MS metabolomics platform was employed using a targeted approach. To measure immune markers, Enzyme-linked immunosorbent assays and the Particle-enhanced turbidimetric assay was used. Results After adjusting for covariates, sCD163 (p = 0.042) and KA (p = 0.031) were higher in participants with Tat signatures N24 and R57, respectively, and amino acid variation at position 24 (adj R2 = 0.048, β = -0.416, p = 0.042) and 57 (adj R2 = 0.166, β = 0.535, p = 0.031) of Tat were associated with sCD163 and KA, respectively. Conclusions These preliminary findings suggest that amino acid variation in Tat may have an influence on underlying pathogenic HIV-1 mechanisms and therefore, this line of work merits further investigation.
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background Cardiovascular disease is a major cause of morbidity in an aging HIV population. However, risk estimation with the most frequent equations usually classifies HIV patients as having a low or moderate risk. Several studies have described a very high prevalence of subclinical atherosclerosis in a middle-aged, non-HIV population. There is insufficient body of knowledge to understand if this is the case in people living with HIV (PLWH). We aim to calculate the proportion of patients with subclinical atherosclerosis in a single site cohort of HIV-infected subjects. Methods We have analyzed chronically HIV infected adults (≥ 18 years) who were on active follow-up in an HIV unit specialized in the care of cardiovascular health. The most recent clinical visit and vascular ultrasonography were used to assess the objectives of our research. Our primary objective was to describe the proportion of participants with subclinical atherosclerosis (focal protrusion into the lumen > 0.5 mm or > 50% of the surrounding IMT or a diffuse thickness > 1.5 mm) in a single site cohort of PLWH. Carotid and iliofemoral territories were evaluated. As a secondary objective we have run a multivariate analysis to determine which HIV and non-HIV factors might be related with the presence of atherosclerotic plaques. Findings We included a total of 463 participants between November 2017 to October 2019. Subjects were predominantly male (84.2%) with a mean age of 48.8 years (SD 10.7). Hypercholesterolemia (36%) was the most prevalent comorbidity followed by Hypertension (18%) and Hypertriglyceridemia (16%). Mean duration of HIV infection is 12.3 years. Overall, participants had been receiving cART for a median of 9.5 years. Subclinical atherosclerosis was found in 197 subjects (42.5%; CI 95% [38.0–47.2]). The disease was found more frequently in the femoral arteries (37.8%) than in the carotid vascular bed (18.6%). Despite some HIV factors correlated with the presence of plaques in a univariate analysis (e.g., time with HIV-1 RNA > 50 copies/mL or time from HIV diagnosis), the only two explanatory factors that remained associated with the presence of atherosclerotic plaques in the multivariate analysis were smoking (OR 5.47, 95% CI 3.36 – 8.90) and age (OR 1.13, 95%CI 1.10 – 1.16). Interpretation We have found a very high prevalence of subclinical atherosclerosis among our cohort of PLWH. Despite having analyzed several HIV factors, age and smoking have been found to be the only factors associated with the development of atherosclerotic plaques.
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background Pregnancy is a critical time for women, making them more susceptible to infectious diseases like COVID-19. This study aims to determine the immunogenicity of COVID-19 in pregnant women who have been infected compared to those who have received the inactive COVID-19 vaccine. Materials and methods In this retrospective cohort study, pregnant women who received the inactivated COVID-19 vaccine (Sinopharm) and those with a history of COVID-19 infection during pregnancy were studied. Participants who had experienced stillbirth, received different COVID-19 vaccines, or had intrauterine fetal death were excluded from the study. Overall, the study included 140 participants. The participants were divided into two groups of 70 participants - pregnant women who received the Sinopharm vaccine and pregnant women who had COVID-19 infection during pregnancy. Before delivery, blood samples were collected from all mothers to evaluate the maternal immunoglobulin G (IgG) level. Blood samples were also taken from the baby’s umbilical cord during delivery to measure the newborn’s IgG level. Additionally, blood samples were collected from babies whose mothers showed signs of acute infection to measure their IgM levels and evaluate vertical transmission. Findings The study found a significant relationship between the mean level of maternal IgG and umbilical cord IgG within the groups (P
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background Continuous monitoring of antimicrobial resistance (AMR) in Uganda involves testing bacterial isolates from clinical samples at national and regional hospitals. Although the National Microbiology Reference Laboratory (NMRL) analyzes these isolates for official AMR surveillance data, there\'s limited integration into public health planning. To enhance the utilization of NMRL data to better inform drug selection and public health strategies in combating antibiotic resistance, we evaluated the trends and spatial distribution of AMR to common antibiotics used in Uganda. Methods We analyzed data from pathogenic bacterial isolates from blood, cerebrospinal, peritoneal, and pleural fluid from AMR surveillance data for 2018–2021. We calculated the proportions of isolates that were resistant to common antimicrobial classes. We used the chi-square test for trends to evaluate changes in AMR resistance over the study period. Results Out of 537 isolates with 15 pathogenic bacteria, 478 (89%) were from blood, 34 (6.3%) were from pleural fluid, 21 (4%) were from cerebrospinal fluid, and 4 (0.7%) were from peritoneal fluid. The most common pathogen was Staphylococcus aureus (20.1%), followed by Salmonella species (18.8%). The overall change in resistance over the four years was 63–84% for sulfonamides, fluoroquinolones macrolides (46–76%), phenicols (48–71%), penicillins (42–97%), β-lactamase inhibitors (20–92%), aminoglycosides (17–53%), cephalosporins (8.3–90%), carbapenems (5.3–26%), and glycopeptides (0–20%). There was a fluctuation in resistance of Staphylococcus aureus to methicillin (60%-45%) (using cefoxitin resistance as a surrogate for oxacillin resistance) Among gram-negative organisms, there were increases in resistance to tetracycline (29–78% p
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Introduction Diarrhoea is a major public health concern in developing countries, usually exacerbated by poor water, sanitation and hygiene but its aetiology is under-studied, particularly away from capital cities. We identified diarrhoeagenic Escherichia coli (DEC) from stools collected in Ile-Ife and Ilesa, Osun state, Nigeria and determined their antibiotic resistance profiles. Methods Stool samples from 167 children with diarrhoea and 334 controls under the age of 5 years were cultured for Escherichia coli and Salmonella. Bacterial isolates were identified biochemically and DEC were identified by PCR. Antimicrobial susceptibility testing was by modified Kirby-Bauer disc diffusion method in accordance with the CLSI guidelines. Data were analyzed using Chi-square and Fisher’s exact tests. Result Diarrhoea infection is significantly high among children under 12 months (p = 0.002), caregivers without at least primary school education (p = 0.006), breastfeeding for under 6 months (p˂0.001), and caregivers who were siblings (p = 0.004). DEC was detected in 69(41.3%) cases but only 86(25.7%) controls (p
Læs mere Tjek på PubMedBMC Infectious Diseases, 10.09.2024
Tilføjet 10.09.2024
Abstract Background Brucellosis is a global public health concern and occurs mainly in young adults and the elderly, with children having a lower incidence, thus often leading to delayed treatment. This study aimed to describe the epidemiologic features and clinical characteristics of brucellosis in children. Methods In this retrospective study, the clinical data of five children diagnosed with brucellosis in Anhui Provincial Children’s Hospital between January 1, 2021 and December 30, 2022 were analyzed. Results All five cases were from non-pastoral areas, among which three have a history of livestock exposure and originated from the countryside. All patients had medium-high grade fever, mostly accompanied by night sweats and malaise, and three had joint pains. Laboratory tests showed that their white blood cell count was normal or mildly raised, with lymphocytes as the predominant cell population. Four patients had anemia, four had aspartate aminotransferase and alanine aminotransferase abnormality, and two had elevated ferritin levels. All blood samples were positive for Brucella culture, one of which had positive bone marrow culture, and all had positive serology test results. All patients were treated with rifampicin, in combination with sulfamethoxazole or doxycycline for 6 weeks following diagnosis. Four children had a good prognosis, but one child had recurrent joint pain. Conclusions The epidemiologic history of children from non-pastoral areas with brucellosis is often unclear; clinical manifestations and laboratory tests lack specificity; and they are easily delayed diagnosis. Clinicians should remain vigilant regarding the possibility of this disease in children with fever of unknown origin. The epidemiological history should be investigated in detail to improve the diagnostic ability of brucellosis. We recommend emphasizing serological testing. Children with brucellosis who receive timely diagnosis and standardized treatment can expect a favorable prognosis.
Læs mere Tjek på PubMed